Skip to Main Content

Author Details

Michel J Grothe
Instituto de Salud Carlos III
2010
135
40
PMIDPaper TitleJournal TitlePublished Year
37975822Impaired cholinergic integrity of the colon and pancreas in dementia with Lewy bodies.Brain2024
36008119Differential Effects of Tau Stage, Lewy Body Pathology, and Substantia Nigra Degeneration on <sup>18</sup>F-FDG PET Patterns in Clinical Alzheimer Disease.J Nucl Med2023
37838742Correction: Differential response to donepezil in MRI subtypes of mild cognitive impairment.Alzheimers Res Ther2023
37578787Increased Medial Temporal Tau Positron Emission Tomography Uptake in the Absence of Amyloid-β Positivity.JAMA Neurol2023
37606273Basal-Forebrain Cholinergic Nuclei Alterations are Associated With Medication and Cognitive Deficits Across the Schizophrenia Spectrum.Schizophr Bull2023
37638433Cortical Amyloid Burden Relates to Basal Forebrain Volume in Subjective Cognitive Decline.J Alzheimers Dis2023
37492892Basal Forebrain Atrophy, Cortical Thinning, and Amyloid-β Status in Parkinson's disease-Related Cognitive Decline.Mov Disord2023
37353809Differential response to donepezil in MRI subtypes of mild cognitive impairment.Alzheimers Res Ther2023
37284793Characteristics of amnestic patients with hypometabolism patterns suggestive of Lewy body pathology.Brain2023
37279796Severe cholinergic terminal loss in newly diagnosed dementia with Lewy bodies.Brain2023
37403733Structural and molecular cholinergic imaging markers of cognitive decline in Parkinson's disease.Brain2023
37327374Towards in vivo PET imaging of primary age-related tauopathy.Brain2023
36912400Peripheral Inflammation Is Associated with Dopaminergic Degeneration in Parkinson's Disease.Mov Disord2023
36898615MRI-based basal forebrain atrophy and volumetric signatures associated with limbic TDP-43 compared to Alzheimer's disease pathology.Neurobiol Dis2023
35971593Differential diagnosis of amnestic dementia patients based on an FDG-PET signature of autopsy-confirmed LATE-NC.Alzheimers Dement2023
34176042Cholinergic basal forebrain and hippocampal structure influence visuospatial memory in Parkinson's disease.Brain Imaging Behav2022
35609990Neuropathologic Features of Antemortem Atrophy-Based Subtypes of Alzheimer Disease.Neurology2022
35431891Reduction in Volume of Nucleus Basalis of Meynert Is Specific to Parkinson's Disease and Progressive Supranuclear Palsy but Not to Multiple System Atrophy.Front Aging Neurosci2022
35852918Clinical and structural brain correlates of hypomimia in early-stage Parkinson's disease.Eur J Neurol2022
35619830Disentangling tau and brain atrophy cluster heterogeneity across the Alzheimer's disease continuum.Alzheimers Dement (N Y)2022
35226405CSF biomarkers and plasma p-tau181 as predictors of longitudinal tau accumulation: Implications for clinical trial design.Alzheimers Dement2022
35068451Age and Anterior Basal Forebrain Volume Predict the Cholinergic Deficit in Patients with Mild Cognitive Impairment due to Alzheimer's Disease.J Alzheimers Dis2022
35122358Antemortem basal forebrain atrophy in pure limbic TAR DNA-binding protein 43 pathology compared with pure Alzheimer pathology.Eur J Neurol2022
35006106Brain FDG PET for Short- to Medium-Term Prediction of Further Cognitive Decline and Need for Assisted Living in Acutely Hospitalized Geriatric Patients With Newly Detected Clinically Uncertain Cognitive Impairment.Clin Nucl Med2022
34969939Association of β-Amyloid and Basal Forebrain With Cortical Thickness and Cognition in Alzheimer and Lewy Body Disease Spectra.Neurology2022
35085959Increased homocysteine levels correlate with cortical structural damage in Parkinson's disease.J Neurol Sci2022
30697878Effective connectivity in the default mode network is distinctively disrupted in Alzheimer's disease-A simultaneous resting-state FDG-PET/fMRI study.Hum Brain Mapp2021
33521872Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia.Eur J Nucl Med Mol Imaging2021
33842683Structural MRI of the basal forebrain as predictor of cognitive response to galantamine in healthy older adults-A randomized controlled double-blinded crossover study.Alzheimers Dement (N Y)2021
33895633Differential patterns of gray matter volumes and associated gene expression profiles in cognitively-defined Alzheimer's disease subgroups.Neuroimage Clin2021
33782308Levodopa-Induced Dyskinesia in Parkinson Disease Specifically Associates With Dopaminergic Depletion in Sensorimotor-Related Functional Subregions of the Striatum.Clin Nucl Med2021
33608059Data-driven FDG-PET subtypes of Alzheimer's disease-related neurodegeneration.Alzheimers Res Ther2021
34674764In vivo staging of regional amyloid progression in healthy middle-aged to older people at risk of Alzheimer's disease.Alzheimers Res Ther2021
34462992FEOBV-PET to quantify cortical cholinergic denervation in AD: Relationship to basal forebrain volumetry.J Neuroimaging2021
34188186Lower cholinergic basal forebrain volumes link with cognitive difficulties in schizophrenia.Neuropsychopharmacology2021
34266917Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at Autopsy.Neurology2021
34171095Aberrant Claustrum Microstructure in Humans after Premature Birth.Cereb Cortex2021
34144230In vivo cholinergic basal forebrain degeneration and cognition in Parkinson's disease: Imaging results from the COPPADIS study.Parkinsonism Relat Disord2021
34373525The relationship between cholinergic system brain structure and function in healthy adults and patients with mild cognitive impairment.Sci Rep2021
33257949Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.Brain2021
33337372Association of TDP-43 Pathology with Global and Regional 18F-Florbetapir PET Signal in the Alzheimer's Disease Spectrum.J Alzheimers Dis2021
33427873Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease.JAMA Neurol2021
33475761Reduced [<sup>18</sup>F]flortaucipir retention in white matter hyperintensities compared to normal-appearing white matter.Eur J Nucl Med Mol Imaging2021
32125613Metabolic and amyloid PET network reorganization in Alzheimer's disease: differential patterns and partial volume effects.Brain Imaging Behav2021
30899092The BDNF<sub>Val66Met</sub> SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer's disease.Mol Psychiatry2021
32291113In vivo staging of regional amyloid deposition predicts functional conversion in the preclinical and prodromal phases of Alzheimer's disease.Neurobiol Aging2020
32035186Cholinergic white matter pathways make a stronger contribution to attention and memory in normal aging than cerebrovascular health and nucleus basalis of Meynert.Neuroimage2020
33305264Comparison of subtyping methods for neuroimaging studies in Alzheimer's disease: a call for harmonization.Brain Commun2020
33395986Multimodal MRI analysis of basal forebrain structure and function across the Alzheimer's disease spectrum.Neuroimage Clin2020
33104026Impairment of Everyday Spatial Navigation Abilities in Mild Cognitive Impairment Is Weakly Associated with Reduced Grey Matter Volume in the Medial Part of the Entorhinal Cortex.J Alzheimers Dis2020
  • 1 - 50 of 135

Recommended Authors

Massachusetts General Hospital, Harvard Medical School
Career Start Year 2012
Number of shared co-authors 24
Perelman School of Medicine University of Pennsylvania
Career Start Year 2011
Number of shared co-authors 6
University of Pennsylvania
Career Start Year 2011
Number of shared co-authors 8
Center for Lifespan Changes in Brain and Cognition, University of Oslo
Career Start Year 2008
Number of shared co-authors 0
Mayo Clinic Rochester
Career Start Year 2006
Number of shared co-authors 6
Massachusetts General Hospital, Harvard Medical School
Career Start Year 2004
Number of shared co-authors 26
Banner Alzheimer's Institute, University of California
Career Start Year 2001
Number of shared co-authors 22
UCSF Weill Institute for Neurosciences, University of California san francisco
Career Start Year 2000
Number of shared co-authors 24
University of California san francisco
Career Start Year 2000
Number of shared co-authors 13
Brain Health Imaging Institute
Career Start Year 1999
Number of shared co-authors 19
Duke University
Career Start Year 1996
Number of shared co-authors 19
University of California Davis
Career Start Year 1996
Number of shared co-authors 20
Institute of Psychiatry, King's College London
Career Start Year 1994
Number of shared co-authors 14
Beijing Normal University
Career Start Year 1993
Number of shared co-authors 27
UCSF Weill Institute for Neurosciences, University of California san francisco
Career Start Year 1993
Number of shared co-authors 18
Evelyn F. McKnight Brain Institute, University of Arizona
Career Start Year 1992
Number of shared co-authors 19
University of California
Career Start Year 1991
Number of shared co-authors 3
University of California San Diego
Career Start Year 1991
Number of shared co-authors 8
University of Kentucky
Career Start Year 1991
Number of shared co-authors 23
University of Kentucky
Career Start Year 1990
Number of shared co-authors 21
University of Pittsburgh
Career Start Year 1989
Number of shared co-authors 28
Eisai Inc.
Career Start Year 1989
Number of shared co-authors 19
UCSF Weill Institute for Neurosciences, University of California san francisco
Career Start Year 1985
Number of shared co-authors 20
Helen Wills Neuroscience Institute, University of California Berkeley
Career Start Year 1984
Number of shared co-authors 31
Banner Alzheimer's Institute
Career Start Year 1984
Number of shared co-authors 32
Sunnybrook Research Institute, University of Toronto
Career Start Year 1981
Number of shared co-authors 24
Johns Hopkins University School of Medicine
Career Start Year 1979
Number of shared co-authors 30
Mayo Clinic Rochester
Career Start Year 1975
Number of shared co-authors 19
Wien Center for Alzheimer's Disease and Memory Disorders, Mount Sinai Medical Center
Career Start Year 1975
Number of shared co-authors 22
Mayo Clinic Rochester
Career Start Year 1968
Number of shared co-authors 29

Collaborators

University of Gothenburg
Co-authored papers 11
Massachusetts General Hospital, the Gordon Center for Medical Imaging
Co-authored papers 5
Hospital Israelita Albert Einstein - Sao Paulo
Co-authored papers 4
Co-authored papers 3
Brigham and Women's Hospital, Massachusetts General Hospital, Harvard Medical School
Co-authored papers 2
Brigham and Women's Hospital, Massachusetts General Hospital
Co-authored papers 2
Gordon Center for Medical Imaging, Massachusetts General Hospital
Co-authored papers 2
University Hospital Bonn
Co-authored papers 2
Mayo Clinic Rochester
Co-authored papers 2
Massachusetts General Hospital, the Gordon Center for Medical Imaging
Co-authored papers 2
Indiana University School of Medicine
Co-authored papers 2
Nathan Kline Institute for Psychiatric Research
Co-authored papers 1
Oregon Center for Aging & Technology
Co-authored papers 1
University of Wisconsin-Madison
Co-authored papers 1
German Center for Neurodegenerative Diseases (DZNE) Munich
Co-authored papers 1
University of New South Wales
Co-authored papers 1
University of California san francisco
Co-authored papers 1
The Hospital for Sick Children
Co-authored papers 1
Massachusetts General Hospital
Co-authored papers 1
Maastricht University
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Massachusetts General Hospital, the Gordon Center for Medical Imaging
Co-authored papers 1
University of Pennsylvania
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 1
Boston University School of Medicine.
Co-authored papers 1
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Indiana University School of Medicine
Co-authored papers 1
University of California Davis
Co-authored papers 1